Perceptive Advisors LLC Regenxbio Inc. Transaction History

Perceptive Advisors LLC

$4.77 Billion
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.89 - $20.82 $4.41 Million - $7.13 Million	342,408 New	342,408 $6.15 Million
Q4 2021 Feb 14, 2022	SELL	$30.19 - $40.28 $2.7 Million - $3.6 Million	-89,283 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.46 - $40.48 $649,200 - $809,599	20,000 Added 28.87%	89,283 $3.47 Million
Q1 2021 May 17, 2021	BUY	$33.61 - $49.95 $2.33 Million - $3.46 Million	69,283 New	69,283 $2.36 Million
Q2 2020 Aug 14, 2020	SELL	$27.75 - $43.44 $14.1 Million - $22.1 Million	-508,000 Closed	0 $0

Q1 2020 May 15, 2020	SELL	$21.5 - $54.2 $2.15 Million - $5.42 Million	-100,000 Reduced 16.45%	508,000 $17.1 Million
Q3 2019 Nov 14, 2019	SELL	$31.84 - $50.88 $11.6 Million - $18.5 Million	-362,997 Reduced 37.38%	608,000 $21.6 Million
Q2 2019 Aug 14, 2019	SELL	$42.0 - $59.29 $7.34 Million - $10.4 Million	-174,729 Reduced 15.25%	970,997 $49.9 Million
Q1 2019 May 15, 2019	BUY	$40.82 - $62.45 $20.4 Million - $31.2 Million	500,000 Added 77.43%	1,145,726 $65.7 Million
Q4 2018 Feb 14, 2019	BUY	$39.11 - $75.15 $6.85 Million - $13.2 Million	175,054 Added 37.19%	645,726 $26.9 Million
Q3 2018 Nov 14, 2018	SELL	$65.0 - $82.15 $25.8 Million - $32.6 Million	-396,434 Reduced 45.72%	470,672 $35.5 Million
Q2 2018 Aug 14, 2018	SELL	$27.2 - $74.35 $380,800 - $1.04 Million	-14,000 Reduced 1.59%	867,106 $62.2 Million
Q1 2018 May 15, 2018	SELL	$24.05 - $37.5 $13 Million - $20.3 Million	-540,080 Reduced 38.0%	881,106 $26.3 Million
Q4 2017 Feb 14, 2018	SELL	$26.0 - $34.6 $520,000 - $692,000	-20,000 Reduced 1.39%	1,421,186 $47.3 Million
Q3 2017 Nov 14, 2017	BUY	$18.0 - $32.95 $25.9 Million - $47.5 Million	1,441,186	1,441,186 $47.5 Million

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

42M

Call Options Held

80.6K

Put Options Held

55.2K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $458M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Account